Does The Reformed Cancer Drug Fund Generate Evidence On Effectiveness? A Cross-sectional Analysis On Publicly Accessible Documentation
View ORCID ProfileHelen Macdonald, View ORCID ProfileBen Goldacre
doi: https://doi.org/10.1101/2020.03.06.19014944
Helen Macdonald
1MSc student, MSc Evidence-Based HealthCare, Oxford University, Department for Continuing Education, Rewley House, 1 Wellington Square, Oxford, OX1 2JA
2The BMJ, BMA House, Tavistock Square, London, WC1H 9JP
Ben Goldacre
3The DataLab, Nuffield Department of Primary Care Health Sciences, Oxford University, Oxford, OX2 6GG, UK
Data Availability
The data are attached to the main paper.
Posted March 08, 2020.
Does The Reformed Cancer Drug Fund Generate Evidence On Effectiveness? A Cross-sectional Analysis On Publicly Accessible Documentation
Helen Macdonald, Ben Goldacre
medRxiv 2020.03.06.19014944; doi: https://doi.org/10.1101/2020.03.06.19014944
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2600)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12135)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4031)
- Geriatric Medicine (380)
- Health Economics (670)
- Health Informatics (2605)
- Health Policy (994)
- Hematology (359)
- HIV/AIDS (832)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3797)
- Nursing (208)
- Nutrition (564)
- Oncology (1989)
- Ophthalmology (576)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (249)
- Palliative Medicine (72)
- Pathology (470)
- Pediatrics (1098)
- Primary Care Research (443)
- Public and Global Health (6470)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (51)
- Transplantation (185)
- Urology (165)